Evidence mapPaperPMID 37513286Full record

ReviewMolecules (Basel, Switzerland)2023

Polyphenols and Neurodegenerative Diseases: Potential Effects and Mechanisms of Neuroprotection.

Raziel Alejandro Arias-Sánchez, Luz Torner, Bertha Fenton Navarro

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 1 pooled it
11.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 1 synthesis or guideline pooled it, 110 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Oral Supplementation withNutrients · 2025
    Article
  17. Article
  18. Review
  19. Special Issue "Targeting Oxidative Stress for Disease: 2nd Edition".International journal of molecular sciences · 2025
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Raziel Alejandro Arias-SánchezLaboratorio de Glicobiología y Farmacognosia, División de Estudios de Posgrado, Facultad de Ciencias Médicas y Biológicas "Dr. Ignacio Chávez", Universidad Michoacana de San Nicolás de Hidalgo (UMSNH), Morelia 58020, Mexico.
Luz TornerCentro de Investigaciones Biomédicas de Michoacán, Instituto Mexicano del Seguro Social, Morelia 58341, Mexico.ORCID 0000-0001-8629-6188
Bertha Fenton NavarroLaboratorio de Glicobiología y Farmacognosia, División de Estudios de Posgrado, Facultad de Ciencias Médicas y Biológicas "Dr. Ignacio Chávez", Universidad Michoacana de San Nicolás de Hidalgo (UMSNH), Morelia 58020, Mexico.ORCID 0000-0002-7273-5458
Universidad Michoacana de San Nicolás de Hidalgo · MXMexican Social Security Institute · MX

Funding

ICTI and CIC-UMSNH PICIR-029, CIC-2023-BFN
6 · The paper itself

Abstract

The increase in people's longevity has, consequently, led to more brain involvement and neurodegenerative diseases, which can become complicated and lead to chronic degenerative diseases, thereby presenting greater public health problems. Medicinal plants have been used since ancient times and contain high concentrations of molecules, including polyphenols. It has been proven that polyphenols, which are present in various natural sources can provide curative effects against various diseases and brain disorders through neuroprotective effects. These neuroprotective effects are mainly attributed to their ability to cross the blood-brain barrier, eliminate reactive oxygen species, and cause the chelation of metal ions. Polyphenols increase the concentration of neurotrophic factors and bind directly to the membrane receptors of these neurotrophic factors, to modulate and activate the signaling cascades that allow the plasticity, survival, proliferation, and growth of neuronal cells, thereby allowing for better learning, memory, and cognition. Moreover, polyphenols have no serious adverse side effects resulting from their consumption.

Indexed as

Neurodegenerative DiseasesNeuroprotective AgentsAntioxidantsFlavonoidsHumansNerve Growth FactorsNeuroprotectionPolyphenolsAntioxidantsFlavonoidsNerve Growth FactorsNeuroprotective AgentsPolyphenolsantioxidantsflavonoidsmedicinal plantsneurodegenerative diseasespolyphenols

Identifiers

PMID37513286
PMCPMC10385962
OpenAlexW4384525913

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.